Philip G. Bardin

Rhinovirus infection increases 5-lipoxygenase and cyclooxygenase-2 in bronchial biopsy specimens from nonatopic subjects.

Rhinovirus is associated with severe asthma exacerbations and raised nasal interleukin-12.

Rhinovirus induction of the CXC chemokine epithelial-neutrophil activating peptide-78 in bronchial epithelium.

Rhinovirus is not detectable in peripheral lung tissue after asthma death.

Rhinovirus infects primary human airway fibroblasts and induces a neutrophil chemokine and a permeability factor.

Roflumilast, an oral, once-daily phosphodiesterase 4 inhibitor, attenuates allergen-induced asthmatic reactions.

Risk factors for intensive care in children with acute asthma.

Vascular endothelial growth factor induction by rhinovirus infection.

Airway inflammation in asymptomatic children with episodic wheeze.

Respirology year-in-review 2007: Clinical science.

Transforming growth factor-beta enhances rhinovirus infection by diminishing early innate responses.

Respirology year-in-review 2008: clinical science.

T-cell cytokine profiles are altered in childhood asthma exacerbation.

Dual-energy X-ray absorptiometry is the method of choice to assess body composition in COPD.

Diagnosis of vocal cord dysfunction in asthma with high resolution dynamic volume computerized tomography of the larynx.

Treatment of obstructive airway diseases with roflumilast, a novel phosphodiesterase 4 inhibitor.

Allergy is an important factor in asthma exacerbation: a pro/con debate.

Laryngeal penetration and aspiration in individuals with stable COPD.

A hypothesis to phenotype COPD exacerbations by aetiology.

Interleukin-6 promotes pulmonary emphysema associated with apoptosis in mice.

Abnormal vocal cord function in difficult-to-treat asthma.

Deregulated Stat3 signaling dissociates pulmonary inflammation from emphysema in gp130 mutant mice.

Protein-protein interactions in RSV assembly: potential targets for attenuating RSV strains.

Middle airway obstruction--it may be happening under our noses.

No H1N1 detected in children admitted to hospital with asthma during the H1N1 pandemic.

Lung T-cell responses to nontypeable Haemophilus influenzae in patients with chronic obstructive pulmonary disease.

Exploring united airways.

Rhinovirus 3C protease facilitates specific nucleoporin cleavage and mislocalisation of nuclear proteins in infected host cells.

IL-6/Stat3-driven pulmonary inflammation, but not emphysema, is dependent on interleukin-17A in mice.

Abnormal vocal cord movement treated with botulinum toxin in patients with asthma resistant to optimised management.

Glucocorticosteroids enhance replication of respiratory viruses: effect of adjuvant interferon.

Dynamic 320-slice CT larynx for detection and management of idiopathic bilateral vocal cord paralysis.

Nontypeable Haemophilus influenzae induces sustained lung oxidative stress and protease expression.

Dynamic laryngeal narrowing in COPD may have effects on the trachea.

Do human rhinovirus infections and food allergy modify grass pollen-induced asthma hospital admissions in children?

The lung immune response to bacteria in chronic obstructive pulmonary disease.

Cardiac dysfunction during exacerbations of chronic obstructive pulmonary disease.

Bacteria in COPD; their potential role and treatment.

Therapeutic Targeting of the IL-6 Trans-Signaling/Mechanistic Target of Rapamycin Complex 1 Axis in Pulmonary Emphysema.

In the Shadow of Fibrosis: Innate Immune Suppression Mediated by Transforming Growth Factor-β.

Activation of cGAS-dependent antiviral responses by DNA intercalating agents.

Targeted Therapy for Severe Asthma: Identifying the Right Patients.

Human Metapneumovirus Infection in Chronic Obstructive Pulmonary Disease: Impact of Glucocorticosteroids and Interferon.

Managing asthma in the era of biological therapies.

Controversies and conundrums in vocal cord dysfunction.

Role of human metapneumovirus and respiratory syncytial virus in asthma exacerbations: where are we now?

Expiratory central airway collapse in stable COPD and during exacerbations.

Dysfunctional breathing is more frequent in chronic obstructive pulmonary disease than in asthma and in health.

Deoxyribonuclease 1 reduces pathogenic effects of cigarette smoke exposure in the lung.

Topoisomerase 1 Inhibition Promotes Cyclic GMP-AMP Synthase-Dependent Antiviral Responses.